World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goal

BACKGROUND: Burkina Faso is a high endemicity country for HBV infection. However, there are few data on vaccine coverage against HBV. The aim of this study was to contribute to the improvement of HBV vaccine coverage in Ouagadougou through HBV screening. METHODS: Awareness campaigns and voluntary he...

Descripción completa

Detalles Bibliográficos
Autores principales: Diarra, Birama, Yonli, Albert Theophane, Ouattara, Abdoul Karim, Zohoncon, Theodora Mahoukèdè, Traore, Lassina, Nadembega, Christelle, Obiri-Yeboah, Dorcas, Yara, Justine, Pietra, Virginio, Ouedraogo, Paul, Bougouma, Alain, Sanogo, Rokia, Simpore, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080359/
https://www.ncbi.nlm.nih.gov/pubmed/30081915
http://dx.doi.org/10.1186/s12985-018-1032-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080359/
https://www.ncbi.nlm.nih.gov/pubmed/30081915
http://dx.doi.org/10.1186/s12985-018-1032-5

Ejemplares similares